Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enbrel and Methotrexate in Plaque Psoriasis
NCT00161655Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2005
- Primary completion
- Aug 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 4
01
Overview
Phase 4, randomised, open-label trial of etanercept in plaque psoriasis (2 arms), sponsored by Pfizer. Primary endpoint: Physician Global Assessment 0 or 1 at 24 weeks. Started Apr 2005; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00161655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161655.